MSB 1.49% $1.02 mesoblast limited

Give Tommy a Headline!, page-40

  1. 509 Posts.
    lightbulb Created with Sketch. 380
    Johnson & Johnson the second-largest Pharmaceutical company have always been in debt. Around US $32 billion dollars ytd to be exact. debt isn't always a bad thing. But I agree product to market would be valuable at this stage of the cycle. I don't think it's fair to say they haven't delivered anything yet though.
    Last edited by Tunnah: 31/08/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.